Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from staphylococcus aureus

Journal of Bacteriology

Volumn 194, Issue 19, 2012, Pages 5294-5304

  Parsons, Joshua B ^a   Yao, Jiangwei ^a   Frank, Matthew W ^a   Jackson, Pamela ^a   Rock, Charles O ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; BACTERIAL PROTEIN; CARRIER PROTEIN; FATTY ACID; GLYCEROL ETHER; GROWTH INHIBITOR; LIPID; LOW MOLECULAR WEIGHT PROTEIN; OLEIC ACID; PALMITOLEIC ACID; PHOSPHOLIPID; SPHINGOSINE; TEICHOIC ACID; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL CELL WALL; BACTERIAL GROWTH; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; FATTY ACID METABOLISM; GROWTH DISORDER; INNATE IMMUNITY; ISOMER; MEMBRANE DAMAGE; MEMBRANE DEPOLARIZATION; NUCLEOTIDE SEQUENCE; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CELL MEMBRANE; CYTOPLASM; FATTY ACIDS; GENE EXPRESSION REGULATION, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PERMEABILITY; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 84868308568     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00743-12     Document Type: Article

References (55)

1. Balemans W, et al. 2010. Essentiality of FASII pathway for Staphylococcus aureus. Nature 463:E3. doi:10.1038/nature08667.
2. Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
3. Brinster S, et al. 2009. Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature 458:83-86.
4. Brinster S, et al. 2010. Reply to "Essentiality of FASII pathway for Staphylococcus aureus." Nature 463:E4. doi:10.1038/nature08668.
5. Butcher GW, King G, Dyke KG. 1976. Sensitivity of Staphylococcus aureus to unsaturated fatty acids. J. Gen. Microbiol. 94:290-296.
6. Caldwell RB, Lattemann CT. 2004. Simple and reliable method to precipitate proteins from bacterial culture supernatant. Appl. Environ. Microbiol. 70:610-612.
7. Chamberlain NR, et al. 1991. Correlation of carotenoid production, decreased membrane fluidity, and resistance to oleic acid killing in Staphylococcus aureus 18Z. Infect. Immun. 59:4332-4337.
8. Chambers HF, DeLeo FR. 2009. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7:629-641.
9. Clarke SR, et al. 2007. The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. Cell Host Microbe 1:199-212.
10. Collins LV, et al. 2002. Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J. Infect. Dis. 186:214-219.
11. D'Elia MA, et al. 2006. Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathway. J. Bacteriol. 188:4183-4189.
12. Demchick P, Koch AL. 1996. The permeability of the wall fabric of Escherichia coli and Bacillus subtilis. J. Bacteriol. 178:768-773.
13. DiRusso CC, Black PN, Weimar JD. 1999. Molecular inroads into the regulation and metabolism of fatty acids, lessons from bacteria. Prog. Lipid Res. 38:129-197.
14. Domenech P, Reed MB, Barry CE, III. 2005. Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect. Immun. 73:3492-3501.
15. Fischer CL, et al. 2012. Antibacterial activity of sphingoid bases and fatty acids against gram-positive bacteria and gram-negative bacteria. Antimicrob. Agents Chemother. 56:1157-1161.
16. Fujita Y, Matsuoka H, Hirooka K. 2007. Regulation of fatty acid metabolism in bacteria. Mol. Microbiol. 66:829-839.
17. Galbraith H, Miller TB. 1973. Effect of long-chain fatty acids on bacterial respiration and amino acid uptake. J. Appl. Bacteriol. 36:659-675.
18. Georgel P, et al. 2005. A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria. Infect. Immun. 73:4512-4521.
19. Greenway DL, Dyke KG. 1979. Mechanism of the inhibitory action of linoleic acid on the growth of Staphylococcus aureus. J. Gen. Microbiol. 115:233-245.
20. Hasper HE, de Kruijff B, Brekink E. 2004. Assembly and stability of nisin-lipid II pores. Biochemistry 43:11567-11575.
21. Heczko PB, Lutticken R, Hryniewicz W, Neugebauer M, Pulverer G. 1979. Susceptibility of Staphylococcus aureus and group A, B, C, and G streptococci to free fatty acids. J. Clin. Microbiol. 9:333-335.
22. Jackowski S, Rock CO. 1983. Ratio of active to inactive forms of acyl carrier protein in Escherichia coli. J. Biol. Chem. 258:15186-15191.
23. Jezek P, et al. 1998. Fatty acid cycling mechanism and mitochondrial uncoupling proteins. Biochim. Biophys. Acta 1365:319-327.
24. Jiang Y, Chan CH, Cronan JE. 2006. The soluble acyl-acyl carrier protein synthetase of Vibrio harveyi B392 is a member of the medium-chain acyl-CoA synthetase family. Biochemistry 45:10008-10019.
25. Jiang Y, Morgan-Kiss RM, Campbell JW, Chan CH, Cronan JE. 2010. Expression of Vibrio harveyi acyl-ACP synthetase allows efficient entry of exogenous fatty acids into the Escherichia coli fatty acid and lipid A synthetic pathways. Biochemistry 49:718-726.
26. Kamp F, Zakim D, Zhang F, Noy N, Hamilton JA. 1995. Fatty acid flip-flop in phospholipid bilayers is extremely fast. Biochemistry 34: 11928-11937.
27. Kenny JG, et al. 2009. The Staphylococcus aureus response to unsaturated long-chain free fatty acids: survival mechanisms and virulence implications. PLoS One 4:e4344.
28. Kitahara T, et al. 2004. Antimicrobial activity of saturated fatty acids and fatty amines against methicillin-resistant Staphylococcus aureus. Biol. Pharm. Bull. 27:1321-1326.
29. Knapp HR, Melly MA. 1986. Bactericidal effects of polyunsaturated fatty acids. J. Infect. Dis. 154:84-94.
30. Kohler T, Weidenmaier C, Peschel A. 2009. Wall teichoic acid protects Staphylococcus aureus against antimicrobial fatty acids from human skin. J. Bacteriol. 191:4482-4484.
31. Koprivnjak T, Weidenmaier C, Peschel A, Weiss JP. 2008. Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A2 and human β-defensin 3. Infect. Immun. 76:2169-2176.
32. Kreiswirth BN, et al. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305:709-712.
33. Kumar GB, Black PN. 1993. Bacterial long-chain fatty acid transport. Identification of amino acid residues within the outer membrane protein FadL required for activity. J. Biol. Chem. 268:15469-15476.
34. Lacks S, Hotchkiss RD. 1960. A study of the genetic material determining an enzyme in pneumococcus. Biochim. Biophys. Acta 39:508-518.
35. Lin YC, et al. 2009. Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo. PLoS One 4:e7499. doi:10.1371/journal.pone.0007499.
36. Lu Y-J, et al. 2006. Acyl-phosphates initiate membrane phospholipid synthesis in gram-positive pathogens. Mol. Cell 23:765-772.
37. Lunde CS, et al. 2009. Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II. Antimicrob. Agents Chemother. 53:3375-3383.
38. Mainiero M, et al. 2010. Differential target gene activation by the Staphylococcus aureus two-component system saeRS. J. Bacteriol. 192:613-623.
39. Nociari MM, Shalev A, Benias P, Russo C. 1998. A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J. Immunol. Methods 213:157-167.
40. Novo DJ, Perlmutter NG, Hunt RH, Shapiro HM. 2000. Multiparameter flow cytometric analysis of antibiotic effects on membrane potential, membrane permeability, and bacterial counts of Staphylococcus aureus and Micrococcus luteus. Antimicrob. Agents Chemother. 44:827-834.
41. Parsons JB, Frank MW, Subramanian C, Saenkham P, Rock CO. 2011. Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors. Proc. Natl. Acad. Sci. U. S. A. 108: 15378-15383.
42. Ray PH, Lillich TT, White DC. 1972. Consequences of glycerol deprivation on the synthesis of membrane components in a glycerol auxotroph of Staphylococcus aureus. J. Bacteriol. 112:413-420.
43. Ruzin A, Novick RP. 2000. Equivalence of lauric acid and glycerol monolaurate as inhibitors of signal transduction in Staphylococcus aureus. J. Bacteriol. 182:2668-2671.
44. Sado-Kamdem SL, Vannini L, Guerzoni ME. 2009. Effect of α-linolenic, capric and lauric acid on the fatty acid biosynthesis in Staphylococcus aureus. Int. J. Food Microbiol. 129:288-294.
45. Schlievert PM, Deringer JR, Kim MH, Projan SJ, Novick RP. 1992. Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrob. Agents Chemother. 36:626-631.
46. Silverman JA, Perlmutter NG, Shapiro HM. 2003. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 47:2538-2544.
47. Smith KR, Thiboutot DM. 2008. Thematic review series: skin lipids. Sebaceous gland lipids: friend or foe? J. Lipid Res. 49:271-281.
48. Sondén B, et al. 2005. Gap, a mycobacterial specific integral membrane protein, is required for glycolipid transport to the cell surface. Mol. Microbiol. 58:426-440.
49. Takigawa H, Nakagawa H, Kuzukawa M, Mori H, Imokawa G. 2005. Deficient production of hexadecanoic acid in the skin is associated in part with the vulnerability of atopic dermatitis patients to colonization by Staphylococcus aureus. Dermatology 211:240-248.
50. Wiedemann I, Benz R, Sahl HG. 2004. Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study. J. Bacteriol. 186:3259-3261.
51. Wille JJ, Kydonieus A. 2003. Palmitoleic acid isomer (C16:1Δ6) in human skin sebum is effective against gram-positive bacteria. Skin Pharmacol. Appl. Skin Physiol. 16:176-187.
52. Zhang Y-M, Marrakchi H, Rock CO. 2002. The FabR (YijC) transcription factor regulates unsaturated fatty acid biosynthesis in Escherichia coli. J. Biol. Chem. 277:15558-15565.
53. Zhang Y-M, Rock CO. 2008. Membrane lipid homeostasis in bacteria. Nat. Rev. Microbiol. 6:222-233.
54. Zheng CJ, et al. 2005. Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Lett. 579:5157-5162.
55. Zhong J, Karberg M, Lambowitz AM. 2003. Targeted and random bacterial gene disruption using a group II intron (targetron) vector containing a retrotransposition-activated selectable marker. Nucleic Acids Res. 31:1656-1664.